Research

Whilst biomedical innovation continues to deliver spectacular progress within areas such as oncology, neurology and genetics, non-adherence remains a key stumbling block in many areas of medicine. The challenges of non-adherence within chronic disease in particular is now seen as one of the most pressing issues facing healthcare providers.

One of the barriers for researchers is the complexity and scope of non-adherence influence. It is often sub-conscious, driven by conflicting goals and is highly context sensitive. What can seem a series of uncomplicated and rational decision choices can be subverted for example by patient self-esteem goals, inappropriate social comparisons or misattributions of causality. There appears to be no definitive lens or paradigm in which patient adherence has been fully captured.

One area that shows promising potential is the role of risk bias. Biased perceptions of risk can distort perceptions of susceptibility and the motivations to adhere to health protective medication or lifestyle interventions. In many chronic disease areas such as cardiovascular disease patients face a multiplicity of choices often accompanied by complex probabilistic outcome scenarios. Information availability rarely equates to information symmetry. What can appear to the physician as shared decision making can often mask significant confusion, anxiety or disengagement on behalf of the patient. Under threat and uncertainty, straightforward choices can become surprisingly complex and challenging. In these situations, biased risk perceptions can dominate, often having a substantial impact on assumptions, attitudes, beliefs and intentions towards health preventation.

Unrealistic optimism (the unjustified belief that a health threat is less serious than objective evidence would indicate) is of particular interest. In many areas of healthcare, it can play both positive and negative roles in optimising health behaviour. In cardiovascular disease, this dual role is particularly relevant. In prevention, unrealistic optimism can encourage the formation of adherence barriers by reducing the perception of personal risk. Conversely, in patients with established CVD morbidity, it can play an important role in maintaining positive health behaviours and preventing the development of psychosocial complications.

Whilst unrealistic optimism has been widely studied within cardiovascular disease, often the research has been heterogeneous and held back by definitional and methodological differences in study design. In other cases, conflicting results have been left unaddressed by future studies. After a flurry of research over the past few decades unrealistic optimism continues to provide as many answers to our understanding of health behaviour as it raises questions.

This research will seek to address a number of inconsistencies within the understanding of health risk perception bias. It includes a systematic review which will draw together the important recent research and look to provide additional synthesis and insight. Additionally it will explore a number of the key antecedents that appear to influence the development of unrealistic optimism during CVD screening and preventative intervention. The intended objective of the combined studies will be to provide additional clinical insight to help guide clinicians manage the phenomenon of  health risk bias within cardiovascular disease.

Research Interests

  • The Psychology of Risk
  • Unrealistic Optimism
  • Judgement & Decision Making
  • Cognitive Processing
  • Expectancies
  • Lifestyle & Medication Adherence
  • Role of Health Literacy in Risk Assesment
  • Behaviour Change

RESEARCH FACULTY:

Kings College London | Institute of Pharmaceutical Sciences | Clinical Practice & Medication Use. 

This group integrates clinical practice and medication-related research activity across King’s Health Partners, namely King’s College London and the local NHS Foundation Trusts, Guy’s and St Thomas’, King’s College Hospital, and South London and Maudsley. The group consists of both academic staff based at King’s College London and clinical academics in the Trusts. In addition, the three local partner trusts employ consultant pharmacists (Medication Safety, Paediatrics, Critical Care, Infectious Diseases, Cardiology & Elderly Care) and senior pharmacists who undertake research as part of their job profile.

Supervisor

Professor John Weinman

Professor John Weinman

Professor of Psychology as Applied to Medicines

Previous Research Projects

  • Self-identity processes in adult female running enthusiasts and their impact on self-esteem and consumption behaviour.

    Self-identity processes in adult female running enthusiasts and their impact on self-esteem and consumption behaviour.

    An investigation of the self-worth derived from running and the anxieties driving obsessive participation. In particular the social and cognitive benefits are explored as well as the influences driving runner's consumer behaviour.

    The positive benefits of goal achievement, cardiovascular fitness and weight loss associated with intense exercise together with the social benefits of running group membership, have spawned a growing community of adult female running enthusiasts. Whilst the known endorphin rush provides a biochemical explanation of its immediate psychological benefits, there appears to be a broader spectrum of self-identity motivations and rewards driving participation. Employing an interpretivist approach enthusiast running is explored through the lens of self-identity and self-esteem.

    The research employs semi-structured depth interviews to explore these motivations and behaviours and the drivers of participation frequency. The research also explores the identity and self-esteem rewards that result from commitment to high levels of participation and its value to individual runners. Finally the implication for marketing is explored in light of the findings with reference to the role of running brands in the life of the runners.